<DOC>
	<DOC>NCT00113620</DOC>
	<brief_summary>The purpose of this study is to determine whether dextromethorphan (Neurodex) and quinidine are effective in the treatment of pain of diabetic neuropathy.</brief_summary>
	<brief_title>Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Quinidine</mesh_term>
	<mesh_term>Quinidine gluconate</mesh_term>
	<criteria>Diagnosis of diabetes mellitus Established diabetic therapy for at least 3 months Labsupported diagnosis of painful diabetic distal symmetric sensory/motor polyneuropathy Pain the previous three months Not pregnant Patient failed adequate trial of 3 or more medications or has required narcotics for pain History of torsades de pointes Sensitivity to quinidine or opiate drugs (codeine, etc) Severe pain that could confound the assessment Patient has had any amputations Patient has participated in the past 30 days or is currently participating in another trial Patient has previously received treatment with dextromethorphan and quinidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>distal symmetrical</keyword>
	<keyword>pain</keyword>
	<keyword>lower extremities</keyword>
	<keyword>dextromethorphan</keyword>
</DOC>